GLP-1 (glucagon-like peptide-1) injections are a class of medications that mimic the action of the natural hormone GLP-1, which is involved in metabolic regulation and digestion
Yancopoulos, MD, Board Co-Chair, President & Chief Scientific Officer Number Of Employees: ~15,400 Stage: Public Financial Snapshot: The companys market cap as of July 2026 was $70.54 billion
It was included as a tertiary agent in the 2017 edition of the multi-agency clinical guidelines for the treatment of hypertension (Whelton et al, 2018), but was no longer mentioned in the 2025 AHA/ACC multisociety hypertension guidelines (Jones et al, 2025)
Reporting of prescribing and preparation errors were also higher for compounded medications, the paper found
Key Components of an Effective GLP-1 Prior Authorization Template An effective prior authorization request for GLP-1s requires several core components, though specific insurer requirements may vary
Additionally, insulin resistance increases the number of neuritic plaques by affecting tau phosphorylation, widely considered a pivotal pathological hallmark in Alzheimers disease (Wegmann et al., 2021)